American Capital Advisory, LLC Relmada Therapeutics, Inc. Transaction History

American Capital Advisory, LLC

  • $181 Billion
  • Q4 2024

A detailed history of American Capital Advisory, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, American Capital Advisory, LLC holds 1,954 shares of RLMD stock, worth $586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,954
Previous 1,954 -0.0%
Holding current value
$586
Previous $6.33 Million 83.94%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$2.3 - $4.36 $1,734 - $3,287
754 Added 62.83%
1,954 $6.33 Million
Q4 2023

Apr 09, 2024
BUY
$2.45 - $4.22 $2,940 - $5,064
1,200 New
1,200 $4.97 Million

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $8.58M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email